| pubmed-article:7675325 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7675325 | lifeskim:mentions | umls-concept:C0007450 | lld:lifeskim |
| pubmed-article:7675325 | lifeskim:mentions | umls-concept:C0028128 | lld:lifeskim |
| pubmed-article:7675325 | lifeskim:mentions | umls-concept:C0017067 | lld:lifeskim |
| pubmed-article:7675325 | lifeskim:mentions | umls-concept:C0030274 | lld:lifeskim |
| pubmed-article:7675325 | lifeskim:mentions | umls-concept:C0949370 | lld:lifeskim |
| pubmed-article:7675325 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:7675325 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:7675325 | pubmed:dateCreated | 1995-10-19 | lld:pubmed |
| pubmed-article:7675325 | pubmed:abstractText | This study examined the distribution of NADPH-diaphorase (NADPH-d) activity in cat pancreatic ganglia and the electrophysiological effects of nitric oxide (NO) donors, NO and the effect of endogenously released NO. The majority (64%) of pancreatic ganglion neurons stained positive for NADPH-d. Large nerve trunks contained numerous non-varicose NADPH-d positive fibers. NADPH-d positive nerve fibers within individual ganglia were varicosed. L-Arginine, sodium nitroprusside and NO, applied in the vicinity of the impaled neuron, evoked a hyperpolarizing response and initiated fast excitatory postsynaptic potentials (EPSPs) in the majority of neurons tested. The hyperpolarizing response was not affected by low Ca2+ (0.1 mM), high Mg2+ (15 mM). Pretreatment with nitro-L-arginine increased the amplitude of slow EPSPs in about 50% of neurons tested. These results support the hypothesis that NO plays a role in ganglionic transmission in the cat pancreas. | lld:pubmed |
| pubmed-article:7675325 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7675325 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7675325 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7675325 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7675325 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7675325 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7675325 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7675325 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7675325 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7675325 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7675325 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:7675325 | pubmed:issn | 0304-3940 | lld:pubmed |
| pubmed-article:7675325 | pubmed:author | pubmed-author:SzurszewskiJ... | lld:pubmed |
| pubmed-article:7675325 | pubmed:author | pubmed-author:MillerS MSM | lld:pubmed |
| pubmed-article:7675325 | pubmed:author | pubmed-author:ShiTT | lld:pubmed |
| pubmed-article:7675325 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7675325 | pubmed:day | 9 | lld:pubmed |
| pubmed-article:7675325 | pubmed:volume | 192 | lld:pubmed |
| pubmed-article:7675325 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7675325 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7675325 | pubmed:pagination | 77-80 | lld:pubmed |
| pubmed-article:7675325 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:7675325 | pubmed:meshHeading | pubmed-meshheading:7675325-... | lld:pubmed |
| pubmed-article:7675325 | pubmed:meshHeading | pubmed-meshheading:7675325-... | lld:pubmed |
| pubmed-article:7675325 | pubmed:meshHeading | pubmed-meshheading:7675325-... | lld:pubmed |
| pubmed-article:7675325 | pubmed:meshHeading | pubmed-meshheading:7675325-... | lld:pubmed |
| pubmed-article:7675325 | pubmed:meshHeading | pubmed-meshheading:7675325-... | lld:pubmed |
| pubmed-article:7675325 | pubmed:meshHeading | pubmed-meshheading:7675325-... | lld:pubmed |
| pubmed-article:7675325 | pubmed:meshHeading | pubmed-meshheading:7675325-... | lld:pubmed |
| pubmed-article:7675325 | pubmed:meshHeading | pubmed-meshheading:7675325-... | lld:pubmed |
| pubmed-article:7675325 | pubmed:meshHeading | pubmed-meshheading:7675325-... | lld:pubmed |
| pubmed-article:7675325 | pubmed:meshHeading | pubmed-meshheading:7675325-... | lld:pubmed |
| pubmed-article:7675325 | pubmed:meshHeading | pubmed-meshheading:7675325-... | lld:pubmed |
| pubmed-article:7675325 | pubmed:meshHeading | pubmed-meshheading:7675325-... | lld:pubmed |
| pubmed-article:7675325 | pubmed:meshHeading | pubmed-meshheading:7675325-... | lld:pubmed |
| pubmed-article:7675325 | pubmed:meshHeading | pubmed-meshheading:7675325-... | lld:pubmed |
| pubmed-article:7675325 | pubmed:meshHeading | pubmed-meshheading:7675325-... | lld:pubmed |
| pubmed-article:7675325 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:7675325 | pubmed:articleTitle | Nitric oxide is a neuromodulator in cat pancreatic ganglia: histochemical and electrophysiological study. | lld:pubmed |
| pubmed-article:7675325 | pubmed:affiliation | Department of Physiology and Biophysics, Mayo Clinic, Rochester, MN 55905, USA. | lld:pubmed |
| pubmed-article:7675325 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7675325 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
